Skip to main content

Advertisement

Log in

Rule-based standardised switching of drugs at the interface between primary and tertiary care

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Introduction

Changes in drug treatment are frequently mandatory with hospital admission and discharge because hospital drug formularies are generally restricted to about 3000 drugs as compared to the many times this number – 62,000 in Germany – that are commercially available. Without computerised support, the process involved with switching drugs to a corresponding generic or a therapeutic equivalent is time-consuming and error-prone.

Methods

We have developed and tested a standardised interchange algorithm for subsequent implementation into a computerised decision support system that switches drugs to the corresponding generic or a therapeutic equivalent if they are not listed on the hospital drug formulary.

Results

The algorithm was retrospectively applied to the medication regimens of 120 patients (774 prescribed drugs containing 886 active ingredients) at their time of admission to surgical wards. Of the prescribed drugs, 52.8% (409/774) were part of the hospital drug formulary, thereby rendering a switch unnecessary. The 365 drugs not listed consisted of 392 active ingredients that were successfully switched to a corresponding generic (84.7%) or a therapeutic equivalent (10.2%). No specific switching procedures were defined for only 2.3% (20/886) of the active ingredients. In these cases, the drugs were either discontinued (4/20) or special drug classes, current diseases or co-medication required manual switching (8/20), or the drugs were continued unchanged and ordered from a wholesaler (8/20).

Conclusion

Using a standardised interchange algorithm, pre-admission drug regimens can successfully be switched to drugs on a hospital drug formulary. These findings suggest that a computerised decision support system will likely be useful to support this important practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Himmel W, Tabache M, Kochen MM (1996) What happens to long-term medication when general practice patients are referred to hospital? Eur J Clin Pharmacol 50:253–257

    Article  PubMed  CAS  Google Scholar 

  2. Cornish PL, Knowles SR, Marchesano R, Tam V, Shadowitz S, Juurlink DN, Etchells EE (2005) Unintended medication discrepancies at the time of hospital admission. Arch Intern Med 165:424–429

    Article  PubMed  Google Scholar 

  3. Himmel W, Kochen MM, Sorns U, Hummers-Pradier E (2004) Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther 42:103–109

    PubMed  CAS  Google Scholar 

  4. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW (2003) The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 138:161–167

    PubMed  Google Scholar 

  5. Summers KH, Szeinbach SL (1993) Formularies: the role of pharmacy-and-therapeutics (P&T) committees. Clin Ther 15:433–441; discussion 432

    PubMed  CAS  Google Scholar 

  6. Thuermann PA, Harder S, Steioff A (1997) Structure and activities of hospital drug committees in Germany. Eur J Clin Pharmacol 52:429–435

    Article  Google Scholar 

  7. de Smedt M (1994) Drug formularies—good or evil? A view from the EEC. Cardiology 85[Suppl 1]:41–45

    Article  PubMed  Google Scholar 

  8. Himmel W, Lonker B, Kochen MM (1998) Nonformulary drug requests at an academic hospital in Germany—the role of general practitioners’ long-term medication. Eur J Clin Pharmacol 54:41–46

    Article  PubMed  CAS  Google Scholar 

  9. Massoomi F (1996) Formulary management: antibiotics and therapeutic interchange. Pharm Pract Manag Q 16:11–18

    PubMed  CAS  Google Scholar 

  10. Schachtner JM, Guharoy R, Medicis JJ, Newman N, Speizer R (2002) Prevalence and cost savings of therapeutic interchange among U.S. hospitals. Am J Health Syst Pharm 59:529–533

    PubMed  Google Scholar 

  11. Navarro de Lara S, Font Noguera I, Lerma Gaude V, Lopez Briz E, Martinez Pascual MJ, Poveda Andres JL (2004) Therapeutic interchange of drugs not included in the hospitals pharmacotherapeutic guide: a quality program. Farm Hosp 28:266–274

    PubMed  CAS  Google Scholar 

  12. The European Agency for the Evaluation of Medicinal Products (2001) Note for guidance on the investigation of bioavailability and bioeqivalence. CPMP/EWP/QWP/1401/98. Available at: http://www.emea.ei.int/pdfs/human/ewp/140198en.pdf. Accessed March 20, 2007

  13. Gray T, Bertch K, Galt K, Gonyeau M, Karpiuk E, Oyen L, Sudekum MJ, Vermeulen LC (2005) Guidelines for therapeutic interchange—2004. Pharmacotherapy 25:1666–1680

    Article  PubMed  Google Scholar 

  14. Grace KA, Swiecki J, Hyatt R, Gibbs H, Jones DL, Sheikh M, Spain J, Maneval KW, Viola R, Taylor AJ (2002) Implementation of a therapeutic-interchange clinic for HMG-CoA reductase inhibitors. Am J Health Syst Pharm 59:1077–1082

    PubMed  Google Scholar 

  15. Stoysich A, Massoomi F (2002) Automatic interchange of the ACE inhibitors: decision-making process and initial results. Formulary 37:41–44

    CAS  Google Scholar 

  16. Porta Oltra B, Borras Almenar C, Jimenez Torres NV (2005) Therapeutic interchange standardization for antiotensin II receptor antagonists in the treatment of hypertension in the hospital setting. Farm Hosp 29:104–112

    PubMed  CAS  Google Scholar 

  17. Teich JM, Merchia PR, Schmiz JL, Kuperman GJ, Spurr CD, Bates DW (2000) Effects of computerized physician order entry on prescribing practices. Arch Intern Med 160:2741–2747

    Article  PubMed  CAS  Google Scholar 

  18. Manolakis PG (2007) Prescription drug product substitution decision support. J Am Pharm Assoc (2003) 47:328–338

    Article  Google Scholar 

  19. Sabatini S, Ferguson RM, Helderman JH, Hull AR, Kirkpatrick BS, Barr WH (1999) Drug substitution in transplantation: a National Kidney Foundation White Paper. Am J Kidney Dis 33:389–397

    PubMed  CAS  Google Scholar 

  20. Wall DS, Abel SR (1996) Therapeutic-interchange algorithm for multiple drug classes. Am J Health Syst Pharm 53:1295–1296

    PubMed  CAS  Google Scholar 

  21. Kaltschmidt J, Gallin S, Haefeli WE (2004) Essential functional requirements for an effective electronic drug information system in a hospital (abstract). Int J Clin Pharmacol Ther 42:615

    Google Scholar 

  22. WHO Collaborating Centre for drug Statistics Methology (2002) ATC Index with DDDs. WHO Collaborating Centre, Oslo

    Google Scholar 

  23. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  PubMed  CAS  Google Scholar 

  24. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139

    Article  PubMed  Google Scholar 

  25. Straka RJ, Swanson AL, Parra D (1998) Calcium channel antagonists: morbidity and mortality—what’s the evidence? Am Fam Physician 57:1551–1560

    PubMed  CAS  Google Scholar 

  26. Burnier M, Brunner HR (2000) Angiotensin II receptor antagonists. Lancet 355:637–645

    Article  PubMed  CAS  Google Scholar 

  27. Menz W (2006) AABG: Preisgünstige Therapiealternativen nach §115 SGB V. Insuline. Krankenhauspharmazie 27:93–102. Available at: http://krankenhauspharmazie.de/AABG/KPH-aabg.HTM

    Google Scholar 

  28. Furberg CD, Pitt B (2001) Are all angiotensin-converting enzyme inhibitors interchangeable? J Am Coll Cardiol 37:1456–1460

    Article  PubMed  CAS  Google Scholar 

  29. Djavan B, Marberger M (1999) A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 36:1–13

    Article  PubMed  CAS  Google Scholar 

  30. Fibbe C, Keller J, Layer P (2005) Short practice guideline for the management of gastroesophageal reflux disease. Dtsch Med Wochenschr 130:1970–1973

    Article  PubMed  CAS  Google Scholar 

  31. Maron DJ, Fazio S, Linton MF (2000) Current perspectives on statins. Circulation 101:207–213

    PubMed  CAS  Google Scholar 

  32. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE (2005) Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Can Med Assoc J 173:510–515

    Article  Google Scholar 

  33. Fijn R, Lenderink AW, Egberts AC, Brouwers JR, De Jong-Van DenBerg LT (2001) Assessment of indicators for hospital drug formulary non-adherence. Eur J Clin Pharmacol 57:677–684

    Article  PubMed  CAS  Google Scholar 

  34. Eckdaten der Krankenhausstatistik 2004/2005. Available at: http://www.dkgev.de/dkgev.php/cat/143/title/Eckdaten+Krankenhausstatistik+2005. Accessed May 2, 2007

  35. Abourjaily P, Gouveia WA, Selker HP, Zucker DR (2005) Evaluating the nondrug costs of formulary coverage restrictions. Manag Care 14:50–57

    PubMed  Google Scholar 

  36. Furberg CD, Herrington DM, Psaty BM (1999) Are drugs within a class interchangeable? Lancet 354:1202–1204

    Article  PubMed  CAS  Google Scholar 

  37. Furberg CD, Psaty BM, Herrington DM (2000) Are drugs interchangeable? Lancet 355:317–318

    Article  Google Scholar 

  38. Kereiakes DJ, Willerson JT (2003) Therapeutic substitution: guilty until proven innocent. Circulation 108:2611–2612

    Article  PubMed  Google Scholar 

  39. Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE (2004) Drug interactions in primary care: impact of a new algorithm on risk determination. Clin Pharmacol Ther 76:85–96

    Article  PubMed  CAS  Google Scholar 

  40. Chong PH (2002) Lack of therapeutic interchangeability of HMG-CoA reductase inhibitors. Ann Pharmacother 36:1907–1917

    Article  PubMed  CAS  Google Scholar 

  41. Schwabe U (2007) Arzneiverordnungen 2005 im Ueberblick. In: Schwabe U, Paffrath D (eds) Arzneiverordnungsreport 2006. Springer Medizin, Heidelberg, pp 3–46

    Chapter  Google Scholar 

  42. Meredith P (2003) Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 25:2875–2890

    Article  PubMed  Google Scholar 

  43. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, Stocker DN, Braunschweig S, Kullak-Ublick GA, Galeazzi RL, Follath F, Gasser T, Meier PJ (2000) Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 49:158–167

    Article  PubMed  CAS  Google Scholar 

  44. Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L (2006) Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging 23:49–59

    Article  PubMed  Google Scholar 

  45. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, Jong G, de Hoog M, van den Anker J (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J 320:79–82

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter E. Haefeli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walk, S.U., Bertsche, T., Kaltschmidt, J. et al. Rule-based standardised switching of drugs at the interface between primary and tertiary care. Eur J Clin Pharmacol 64, 319–327 (2008). https://doi.org/10.1007/s00228-007-0402-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-007-0402-5

Keywords

Navigation